Supplemento
Tecnologia migliorata, cliniche più veloci e trattamenti personalizzati
12 giugno 2020
· 20 MIN LETTURA
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original.image_file.100.100.file/royce-chen.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original.image_file.360.360.file/royce-chen.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg"})
Autore
Royce W.S. Chen, MD
Irving Medical Center, Columbia University, Stati Uniti
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.100.100.file/jesse-jung.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.360.360.file/jesse-jung.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.768.768.file/jesse-jung.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/jesse-jung.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.1280.1280.file/jesse-jung.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original./jesse-jung.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original./jesse-jung.jpg"})
Autore
Jesse J. Jung, MD
Specialista in Chirurgia vitreoretinica, East Bay Retina Consultants, Inc., Stati Uniti
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.100.100.file/sunil-shrivastava.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.360.360.file/sunil-shrivastava.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.768.768.file/sunil-shrivastava.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/sunil-shrivastava.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg"})
Autore
Sunil K. Srivastava, MD
Specialista della retina, Cleveland Clinic, Stati Uniti
RIEPILOGO
In che modo le più moderne e avanzate tecnologie consentono di velocizzare il lavoro nelle cliniche e di personalizzare i trattamenti?
In questo supplemento, pubblicato originariamente su Retina Today, un gruppo di esperti esamina due strumenti di imaging - l’angiografia OCT e l’imaging del fondo a campo ultra largo - volti a migliorare la diagnosi e la gestione della malattia.